Subsequent management and outcomes after first-line PARP inhibitors progression in ovarian cancer patients
Abstract Objectives This retrospective study aims to evaluating the subsequent management and outcomes after first-line PARPi progression in Chinese ovarian cancer population. Methods Clinical and pathologic variables, treatment modalities, and outcomes were assessed. We investigated the subsequent...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-04-01
|
| Series: | Journal of Ovarian Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13048-024-01400-9 |